Home > News > Nanogen Announces Type II Diabetes Research Collaboration
May 15th, 2006
Nanogen Announces Type II Diabetes Research Collaboration
Abstract:
Nanogen, Inc. (Nasdaq: NGEN), developer of advanced diagnostic products, has announced a collaboration agreement with Oy Jurilab, Ltd., the Finnish genomics company. The collaboration is designed to identify and validate new prognostic markers for type II diabetes, one of the leading causes of death in the United States.
Source:
prnewswire
Bookmark:
| Related News Press |
Nanomedicine
Remote-control shoots laser at nano-gold to turn on cancer-killing immune cells April 20th, 2018
Observing biological nanotransporters: Chemistry April 19th, 2018
Nanobiotix Shows NBTXR3 Nanoparticles Can Stoke Anti-Tumor Immune Response April 17th, 2018
Announcements
Remote-control shoots laser at nano-gold to turn on cancer-killing immune cells April 20th, 2018
New qubit now works without breaks: A universal design for superconducting qubits has been created April 19th, 2018
Observing biological nanotransporters: Chemistry April 19th, 2018
Salt boosts creation of 2-D materials: Rice University scientists show how salt lowers reaction temperatures to make novel materials April 18th, 2018
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||